To start your customized experience click the start button
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Katie Kosko
Expert discusses three promising options to treat patients with medullary thyroid cancer.
Danielle Bucco
Patients who choose not to have their thyroid cancer treated often have feelings of anxiety and isolation, and are at a risk of disengaging from the health care system because they might not feel supported.
Allie Casey
A recent study found that some late effects are more prevalent in patients who were diagnosed with thyroid cancer before 40 compared to those who were diagnosed at a later age.
Laura Panjwani
Clinical trial enrollment must become speedier for patients with rare diseases such as anaplastic thyroid cancer, says Maria Cabanillas, M.D.
Brielle Urciuoli
Encapsulated follicular variant of papillary thyroid cancer may actually not be cancer at all, according to Yuri E. Nikiforov.
Gina Columbus
Marcia S. Brose discusses Lenvima for patients with progressive radioactive iodine (RAI)-refractory differentiated thyroid cancer. 
Danielle Nicosia
Danielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.
Tony Hagen
Nexavar and Lenvima have significantly altered the treatment paradigm for patients with advanced RAI-refractory differentiated thyroid cancer, with combination strategies hoping to further build upon this success.
Bethany Andrews Rhoten
Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses how patients with cancer can cope with body image issues.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable